These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities. Simsek C; Karanasos A; Magro M; Garcia-Garcia HM; Onuma Y; Regar E; Boersma E; Serruys PW; van Geuns RJ EuroIntervention; 2016 Jan; 11(9):996-1003. PubMed ID: 25349042 [TBL] [Abstract][Full Text] [Related]
23. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057 [TBL] [Abstract][Full Text] [Related]
24. A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance. Boeder NF; Koepp T; Dörr O; Bauer T; Mattesini A; Elsässer A; Möllmann H; Blachutzik F; Achenbach S; Ghanem A; Hamm CW; Nef HM Int J Cardiol; 2016 Oct; 220():706-10. PubMed ID: 27393853 [TBL] [Abstract][Full Text] [Related]
25. Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial. Teeuwen K; van der Schaaf RJ; Adriaenssens T; Koolen JJ; Smits PC; Henriques JP; Vermeersch PH; Tjon Joe Gin RM; Schölzel BE; Kelder JC; Tijssen JG; Agostoni P; Suttorp MJ JACC Cardiovasc Interv; 2017 Jan; 10(2):133-143. PubMed ID: 28104206 [TBL] [Abstract][Full Text] [Related]
26. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study. Vesga B; Hernandez H; Moncada M; Gasior P; Higuera S; Dager A; Arana C; Delgado JA; Généreux P; Maehara A; Granada JF Coron Artery Dis; 2017 Mar; 28(2):126-134. PubMed ID: 27879518 [TBL] [Abstract][Full Text] [Related]
27. Embolization of Fractured Bioresorbable Scaffold Struts: Insights From 2- and 3-Dimensional Optical Coherence Tomography. Capranzano P; Francaviglia B; Capodanno D; Di Salvo ME; Tamburino CI; Santagati FM; Tamburino C JACC Cardiovasc Interv; 2016 Feb; 9(4):e37-e38. PubMed ID: 26777323 [No Abstract] [Full Text] [Related]
28. Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects. Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Röther J; Tröbs M; Schlundt C; Achenbach S; Hamm CW; Nef HM Clin Res Cardiol; 2017 Apr; 106(4):271-279. PubMed ID: 27757522 [TBL] [Abstract][Full Text] [Related]
29. Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions). Azzalini L; Giustino G; Ojeda S; Serra A; La Manna A; Ly HQ; Bellini B; Benincasa S; Chavarría J; Gheorghe LL; Longo G; Miccichè E; D'Agosta G; Picard F; Pan M; Tamburino C; Latib A; Carlino M; Chieffo A; Colombo A Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27765802 [TBL] [Abstract][Full Text] [Related]
30. Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch? Muramatsu T; García-García HM; Serruys PW; Waksman R; Verheye S; JACC Cardiovasc Interv; 2014 May; 7(5):575-6. PubMed ID: 24852807 [No Abstract] [Full Text] [Related]
31. Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry. Heeger CH; Busjahn A; Hildebrand L; Fenski M; Lesche F; Meincke F; Kuck KH; Bergmann MW EuroIntervention; 2016 Jan; 11(9):1004-12. PubMed ID: 25287264 [TBL] [Abstract][Full Text] [Related]
32. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study. Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128 [TBL] [Abstract][Full Text] [Related]
33. Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry. Pereira GTR; La Manna A; Ichibori Y; Vergara-Martel A; Ramos Nascimento B; Samdani AJ; Capodanno D; D'Agosta G; Gravina G; Venuti G; Tamburino C; F Attizzani G Int J Cardiovasc Imaging; 2019 Oct; 35(10):1767-1776. PubMed ID: 31175527 [TBL] [Abstract][Full Text] [Related]